Global Vitro Toxicology Testing Market
حجم السوق بالمليار دولار أمريكي
CAGR : %
فترة التنبؤ |
2024 –2030 |
حجم السوق (السنة الأساسية) |
|
حجم السوق (سنة التنبؤ) |
USD 27,952.36 |
CAGR |
|
اللاعبين الرئيسيين في الأسواق |
|
>السوق العالمية لاختبارات السموم في المختبر، حسب المنتج والخدمة (المواد الاستهلاكية والخدمات والاختبارات والمعدات والبرمجيات)، نقطة نهاية واختبار علم السموم (اختبار الامتصاص والتوزيع والتمثيل الغذائي والإخراج)، اختبار السمية الخلوية، اختبار السمية الجينية، اختبار السمية الجلدية، اختبار السمية العينية، اختبار السمية العضوية، اختبار تهيج الجلد والتآكل والتحسس، اختبار السمية الضوئية، ونقاط نهاية واختبارات السمية الأخرى)، التكنولوجيا (تقنيات زراعة الخلايا، تقنيات الإنتاجية العالية، التصوير الجزيئي ، وتكنولوجيا أوميكس)، الطريقة (الاختبارات الخلوية، الاختبارات الكيميائية الحيوية، نماذج خارج الجسم الحي، ونماذج إن سيليكو)، الصناعة (شركات الأدوية والمستحضرات الصيدلانية الحيوية، التشخيص، الأغذية، المواد الكيميائية، مستحضرات التجميل والمنتجات المنزلية)، قناة التوزيع (العطاء المباشر، مبيعات التجزئة، وغيرها) - الصناعة الاتجاهات والتوقعات حتى عام 2030.
تحليل حجم سوق اختبارات السموم في المختبر
إن سوق اختبارات السموم المختبرية العالمية مجزأة بطبيعتها، حيث تتكون من العديد من اللاعبين العالميين مثل Thermo Fisher Scientific Inc. (الولايات المتحدة)، وLabcorp Drug Development (الولايات المتحدة)، وMerck KGaA (ألمانيا)، وCharles River Laboratories (الولايات المتحدة)، وLonza (سويسرا) وغيرها. إن وجود هذه الشركات ينتج أسعارًا تنافسية لمنتجات اختبارات السموم المختبرية في جميع أنحاء المنطقة. ونظرًا لوجود هؤلاء اللاعبين على المستويين الإقليمي والدولي، يقدم الموردون والمصنعون منتجات بمواصفات وخصائص مختلفة في جميع الميزانيات. إن الطلب المتزايد على منتجات اختبارات السموم المختبرية عالميًا يدفع نمو السوق. بالإضافة إلى ذلك، من المتوقع أن تدفع الصناعات الدوائية والطبية سريعة النمو نمو السوق.
تحلل شركة Data Bridge Market Research أن سوق اختبارات السموم المختبرية العالمية من المتوقع أن يصل إلى 27,952.36 مليون دولار أمريكي بحلول عام 2030، بمعدل نمو سنوي مركب يبلغ 12.3% خلال الفترة المتوقعة. يغطي تقرير السوق هذا أيضًا تحليل الأسعار والتقدم التكنولوجي بعمق.
تقرير القياس |
تفاصيل |
فترة التنبؤ |
2023 إلى 2030 |
سنة الأساس |
2022 |
سنوات تاريخية |
2021 (قابلة للتخصيص حتى 2015 - 2020) |
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية، والأحجام بالوحدات، والتسعير بالدولار الأمريكي |
القطاعات المغطاة |
حسب المنتج والخدمة (المواد الاستهلاكية والخدمات والاختبارات والمعدات والبرامج) ونقطة نهاية علم السموم والاختبار (اختبار الامتصاص والتوزيع والتمثيل الغذائي والإخراج) واختبار السمية الخلوية واختبار السمية الجينية واختبار السمية الجلدية واختبار السمية العينية واختبار سمية الأعضاء واختبار تهيج الجلد والتآكل والتحسس واختبار السمية الضوئية ونقاط نهاية واختبارات السمية الأخرى) والتكنولوجيا ( زراعة الخلايا وتقنيات الإنتاجية العالية والتصوير الجزيئي وتكنولوجيا الجينومات) والطريقة (الاختبارات الخلوية والاختبارات الكيميائية الحيوية ونماذج خارج الجسم الحي ونماذج الحاسوب) والصناعة (شركات الأدوية والمستحضرات الصيدلانية الحيوية والتشخيص والأغذية والمواد الكيميائية ومستحضرات التجميل والمنتجات المنزلية) وقناة التوزيع (العطاء المباشر ومبيعات التجزئة وغيرها) |
الدول المغطاة |
الولايات المتحدة الأمريكية، كندا، المكسيك، ألمانيا، فرنسا، المملكة المتحدة، إيطاليا، إسبانيا، هولندا، روسيا، سويسرا، تركيا، بلجيكا، بقية أوروبا، الصين، اليابان، الهند، كوريا الجنوبية، أستراليا، سنغافورة، تايلاند، ماليزيا، إندونيسيا، الفلبين، بقية دول آسيا والمحيط الهادئ، البرازيل، الأرجنتين، بقية دول أمريكا الجنوبية، جنوب أفريقيا، المملكة العربية السعودية، الإمارات العربية المتحدة، مصر، إسرائيل، وبقية دول الشرق الأوسط وأفريقيا |
الجهات الفاعلة في السوق المشمولة |
Thermo Fisher Scientific Inc.، وLabcorp Drug Development، وMerck KGaA، وCharles River Laboratories، وLonza، وBio-Rad Laboratories, Inc.، وCatalent, Inc، وSGS Société Générale de Surveillance SA، وQIAGEN، وIntertek Group plc.، وEurofins Scientific، وPromega Corporation، وAragen Life Sciences Ltd.، وCyprotex Plc.، وShanghai Medicilon Inc.، وCreative Biolabs، وBioIVT، وAAT Bioquest, Inc.، وGentronix، وIONTOX، وInSphero، وMB Research Laboratories، وCreative Bioarray، وPreferred Cell Systems |
تعريف السوق
تتضمن اختبارات السموم في المختبر اختبار المواد الكيميائية والأدوية وغيرها من المواد لتقييم سميتها المحتملة باستخدام طرق الاختبار في المختبر (غير الحيوانية). تتضمن اختبارات السموم في المختبر استخدام الخلايا أو الأنسجة أو المكونات الخلوية خارج بيئتها الطبيعية لتقييم سلامة المواد والمخاطر المحتملة. يشمل السوق مجموعة واسعة من الاختبارات والتحاليل في المختبر التي تقيم جوانب مختلفة من السمية، بما في ذلك على سبيل المثال لا الحصر السمية الخلوية والسمية الجينية والسرطانية وسمية الأعضاء والسمية التناسلية والسمية البيئية. تُجرى هذه الاختبارات على مزارع الخلايا أو نماذج الأنسجة أو أنظمة أخرى في المختبر لمحاكاة استجابة الأنظمة البيولوجية للمواد السامة المحتملة.
ديناميكيات سوق اختبارات السموم المختبرية العالمية
يتناول هذا القسم فهم محركات السوق والمزايا والفرص والقيود والتحديات. وسيتم مناقشة كل هذا بالتفصيل أدناه:
السائقين
تزايد الطلب على منتجات اختبار السموم
إن النشاط الرئيسي لصناعة الأدوية هو إدارة الجودة. يجب بيع الأدوية في شكل تركيبات معقمة وفعالة علاجيًا وموثوقة ويمكن التنبؤ بأدائها. يتم تطوير عوامل طبية جديدة ومحسنة بسرعة متسارعة. في الوقت نفسه، يتم تطوير طرق تحليلية أكثر دقة وتطورًا لتقييمها. أصدرت إدارة الغذاء والدواء العديد من الوثائق الإرشادية للصناعة، مثل اختبار سلامة مستقلبات الأدوية، ودراسات التمثيل الغذائي في المختبر ودراسات تفاعل الأدوية مع الأدوية بوساطة الناقل، ودراسات التفاعلات الدوائية السريرية.
هناك حاجة إلى منتجات طبية معقمة لسلامة المرضى، إلى جانب حماية شركات الأدوية والأجهزة الطبية من سحب المنتجات، مما يؤدي إلى زيادة الطلب في السوق. لذلك، فإن الطلب المتزايد على منتجات اختبار السموم في صناعة الأدوية والتكنولوجيا الحيوية يدفع نمو السوق.
صناعة الأدوية والأجهزة الطبية سريعة النمو
لقد شهدت صناعة الأدوية والأجهزة الطبية العديد من الاتجاهات والتطورات الثورية، مما أدى إلى تحسين الأدوية المتاحة للمرضى على مستوى العالم بشكل كبير. وكان من الممكن أن نشهد تأثير الذكاء الاصطناعي والبيانات الضخمة على تشخيص وعلاج الأمراض.
إن فعالية الأدوية الحيوية والحماية التي توفرها تساعد شركات الأدوية على النجاح، إلى جانب قدرتها على علاج أمراض لم يكن من الممكن علاجها من قبل. وتدعم فرصة النمو الصحي المستدام خط تطوير الأدوية الحيوية القائم. فمنذ عام 1995، ارتفع عدد براءات الاختراع المقدمة في مجال التكنولوجيا الحيوية بنسبة 25% سنوياً. وهناك أكثر من 1500 جزيء حيوي تخضع حالياً للتجارب السريرية، وكان معدل نجاح الأدوية الحيوية حتى الآن أكثر من ضعف معدل نجاح الأدوية ذات الجزيئات الصغيرة، حيث دخلت 13% من الأدوية الحيوية مرحلة الاختبار الأولى قبل إطلاقها.
إن ازدهار ونمو هذه الصناعات يزيد بشكل متناسب من الطلب على اختبارات السمية لمراقبة جودة المنتجات التي طورتها. لذلك، تعمل صناعات الأدوية والأجهزة الطبية سريعة النمو كمحرك لنمو السوق.
فرصة
تزايد اعتماد منتجات فحص الجودة لمنع سحب المنتجات
تكتسب الأجهزة الطبية والأدوية والمستحضرات البيولوجية أهمية متزايدة في تقديم الرعاية الصحية اليوم. ومع ذلك، فإن المخاوف المستمرة بشأن جودة الأدوية وعمليات سحبها من الأسواق تثير مخاطر صحية محتملة نتيجة لاستخدام هذه الأدوية على المرضى. ومن الأسباب الرئيسية لسحب المنتجات من الأسواق في شركات الأدوية ملف السمية الذي تتسم به أدويتها ومنتجاتها الأخرى، والذي قد يؤدي إلى مضاعفات صحية خطيرة بين المرضى الذين يتناولونها.
يجب أن تتضمن الضوابط أثناء العملية لتتبع وجود السمية الإنتاج المعقم للمنتجات المركبة. لذلك، فإن المراقبة الفعالة والكفؤة للسمية مهمة في الصناعات الدوائية والطبية الحيوية. يجب أن تخضع جميع المنتجات القابلة للحقن أو القابلة للزرع والتي تحمل علامة خالية من المواد المسببة للحمى أو المعقمة لاختبارات السموم قبل إطلاقها. هذا يتجنب السمية لدى المرضى ويجعل من السهل الامتثال للإرشادات التنظيمية وإرشادات ممارسات التصنيع الجيدة الحالية. وبالتالي، فإن التبني المتزايد لمنتجات فحص الجودة لمنع سحب المنتجات يعمل كفرصة لنمو السوق.
ضبط النفس / التحدي
التكلفة العالية المرتبطة باختبارات السموم في المختبر والمنتجات
تم تجهيز أنظمة اختبار السمية الآلية بأحدث التقنيات والميزات المتقدمة. تتمتع بوظائف وميزات واسعة النطاق. يوفر اختبار السمية الآلي الكشف الدقيق والفعال عن السمية. ومع ذلك، من المرجح أن تؤثر التكلفة العالية لهذه الأجهزة على السوق.
وبالتالي، فإن التقدم يشمل اختبار حساسية مضادات الميكروبات الآلي (AST) ، والتخفيف الدقيق، وطرق الأجهزة الآلية السريعة، واختبارات شرائط MIC، والطرق الجينية، وطريقة انتشار القرص، والاختبارات الإلكترونية، وتقنيات متوافقة مع POCT، وكل هذه الميزات المتقدمة تجعل الجهاز مكلفًا. وقد يعمل هذا كعامل مقيد لسوق اختبارات السموم في المختبر.
التطورات الأخيرة
- في يونيو 2023، أعلنت شركة Lonza، وهي شريك تصنيع عالمي لأسواق الأدوية والتكنولوجيا الحيوية والمستحضرات المغذية، أنها استحوذت على شركة Synaffix BV (Synaffix)، وهي شركة تكنولوجيا حيوية تركز على تسويق منصة التكنولوجيا الخاصة بها في المرحلة السريرية لتطوير ADCs. سيساعد هذا الشركة على توسيع حضورها العالمي
- في أكتوبر 2022، أعلنت شركة Thermo Fisher Scientific Inc. أنها ستوسع عمليات مختبرها في هايلاند هايتس بولاية كنتاكي، لمساعدة العملاء على توصيل الأدوية التي تغير حياة المرضى. يوفر المرفق الحالي، الذي يشمل عمليات المختبر المركزي والمؤشرات الحيوية، لعملاء الأدوية الحيوية خدمات مختبرية عالية الجودة لتسريع تطوير الأدوية. ساعد هذا الشركة على توسيع أعمال التشخيص السريري عبر مناطق مختلفة في العالم وساعد في زيادة حضورها العالمي في السوق
نطاق سوق اختبارات السموم المختبرية العالمية
ينقسم سوق اختبارات السموم في المختبر العالمي إلى ستة قطاعات بارزة: المنتج والخدمة، ونقطة النهاية واختبار السموم، والتكنولوجيا، والطريقة، والصناعة، وقناة التوزيع. سيساعدك النمو بين هذه القطاعات على تحليل قطاعات النمو الضئيلة في الصناعات وتزويد المستخدمين بنظرة عامة قيمة على السوق ورؤى لمساعدتهم على اتخاذ قرارات استراتيجية لتحديد تطبيقات السوق الأساسية.
المنتج والخدمة
- المواد الاستهلاكية
- خدمات
- فحص
- المعدات
- برمجة
على أساس المنتج والخدمة، يتم تقسيم سوق اختبار السموم المختبرية العالمي إلى المواد الاستهلاكية والخدمات والاختبارات والمعدات والبرمجيات.
نقطة النهاية واختبار علم السموم
- اختبار ADME (الامتصاص والتوزيع والتمثيل الغذائي والإخراج)
- اختبار السمية الخلوية
- اختبار السمية الجينية
- اختبار السمية الجلدية
- اختبار السمية العينية
- اختبار سمية الأعضاء
- اختبار تهيج الجلد والتآكل والتحسس
- اختبار السمية الضوئية ونقاط النهاية والاختبارات الأخرى للسمية
بناءً على نقطة نهاية علم السموم والاختبار، يتم تقسيم السوق إلى اختبار ADME (الامتصاص والتوزيع والاستقلاب والإخراج)، واختبار السمية الخلوية، واختبار السمية الجينية، واختبار السمية الجلدية، واختبار السمية العينية، واختبار سمية الأعضاء، وتهيج الجلد، والتآكل، واختبار التحسس، واختبار السمية الضوئية، ونقاط نهاية السمية والاختبارات الأخرى.
تكنولوجيا
- تقنيات زراعة الخلايا
- تقنيات الإنتاجية العالية
- التصوير الجزيئي
- تكنولوجيا أوميكس
بناءً على التكنولوجيا، يتم تقسيم السوق إلى تقنيات زراعة الخلايا، وتقنيات الإنتاجية العالية، والتصوير الجزيئي، وتقنية OMICS.
طريقة
- التحاليل الخلوية
- التحاليل الكيميائية الحيوية
- موديلات سابقة
- نماذج حاسوبية
بناءً على الطريقة، يتم تقسيم السوق إلى اختبارات خلوية، واختبارات كيميائية حيوية، ونماذج خارج الجسم الحي، ونماذج حاسوبية.
صناعة
- شركات الأدوية والمستحضرات الصيدلانية الحيوية
- التشخيص
- طعام
- المواد الكيميائية
- مستحضرات التجميل والمنتجات المنزلية
بناءً على الصناعة، يتم تقسيم السوق إلى شركات الأدوية والأدوية الحيوية، والتشخيص، والأغذية، والمواد الكيميائية، ومستحضرات التجميل والمنتجات المنزلية.
قناة التوزيع
- العطاء المباشر
- مبيعات التجزئة
- آحرون
بناءً على قناة التوزيع، يتم تقسيم السوق إلى العطاءات المباشرة ومبيعات التجزئة وغيرها.
تحليل إقليمي/رؤى حول سوق اختبارات السموم العالمية في المختبر
يتم تحليل سوق اختبارات السموم في المختبر العالمي. وكما هو مذكور أعلاه، يتم توفير رؤى حول حجم السوق واتجاهاته حسب البلد والمنتج والخدمة ونقطة النهاية واختبار السموم والتكنولوجيا والطريقة والصناعة وقناة التوزيع.
الدول المشمولة في تقرير السوق هذا هي الولايات المتحدة وكندا والمكسيك وألمانيا وفرنسا والمملكة المتحدة وإيطاليا وإسبانيا وهولندا وروسيا وسويسرا وتركيا وبلجيكا وبقية أوروبا والصين واليابان والهند وكوريا الجنوبية وأستراليا وسنغافورة وتايلاند وماليزيا وإندونيسيا والفلبين وبقية دول آسيا والمحيط الهادئ والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية وجنوب أفريقيا والمملكة العربية السعودية والإمارات العربية المتحدة ومصر وإسرائيل وبقية دول الشرق الأوسط وأفريقيا.
ومن المتوقع أن تهيمن أمريكا الشمالية بسبب الطلب المتزايد على اختبارات السموم، ومن المتوقع أن تعمل التطورات التكنولوجية على تغذية نمو السوق خلال فترة التوقعات في هذه المنطقة. ومن المتوقع أن تهيمن الولايات المتحدة على أمريكا الشمالية بسبب الطلب المتزايد على منتجات اختبار السموم في المختبر. ومن المتوقع أن تهيمن الصين على منطقة آسيا والمحيط الهادئ مع توسع المبادرات الاستراتيجية من قبل اللاعبين الرئيسيين في السوق بشكل كبير. ومن المتوقع أن تهيمن ألمانيا على أوروبا بسبب الصناعات الدوائية والطبية سريعة النمو.
كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغيرات في تنظيم السوق التي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. نقاط البيانات مثل تحليل سلسلة القيمة النهائية والنهائية، والاتجاهات الفنية، وتحليل قوى بورتر الخمس، ودراسات الحالة هي بعض المؤشرات المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية، وتأثير التعريفات الجمركية المحلية، وطرق التجارة أثناء تقديم تحليل توقعات لبيانات الدولة.
تحليل المنافسة وحصة السوق العالمية لاختبارات السموم المختبرية
يوفر المشهد التنافسي العالمي لسوق اختبارات السموم في المختبر تفاصيل عن المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والمالية، والإيرادات المتولدة، وإمكانات السوق، ومبادرات السوق الجديدة، والحضور العالمي، ومواقع الإنتاج والمرافق، والقدرات الإنتاجية، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركات فيما يتعلق بالسوق.
بعض اللاعبين الرئيسيين في السوق الذين يعملون في سوق اختبارات السموم المختبرية العالمية هم Thermo Fisher Scientific Inc. (الولايات المتحدة) و Labcorp Drug Development (الولايات المتحدة) و Merck KGaA (ألمانيا) و Charles River Laboratories (الولايات المتحدة) و Lonza (سويسرا) و Bio-Rad Laboratories, Inc. (الولايات المتحدة) و Catalent, Inc (الولايات المتحدة) و SGS Société Générale de Surveillance SA (سويسرا) و QIAGEN (ألمانيا) و Intertek Group plc. (المملكة المتحدة) و Eurofins Scientific (لوكسمبورج) و Promega Corporation (الولايات المتحدة) و Aragen Life Sciences Ltd. (الهند) و Cyprotex Plc. (المملكة المتحدة) و Shanghai Medicilon Inc. (الصين) و Creative Biolabs (الولايات المتحدة) و BioIVT (الولايات المتحدة) و AAT Bioquest, Inc. (الولايات المتحدة) و Gentronix (المملكة المتحدة) و IONTOX (الولايات المتحدة) و InSphero (الولايات المتحدة) و MB Research Laboratories (الولايات المتحدة) و Creative Bioarray (الولايات المتحدة) و Preferred Cell Systems (الولايات المتحدة) وغيرها.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE SEGMENT LIFELINE CURVE
2.8 MARKET END USER COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS ANALYSIS
5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, INDUSTRY INSIGHTS
6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR TOXICOLOGY TESTING PRODUCTS
7.1.2 RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
7.1.3 RISING INVESTMENT IN R&D BY KEY MARKET PLAYERS
7.1.4 TECHNOLOGICAL ADVANCEMENTS TO DEVELOP NEW TOXICOLOGY TESTING METHODS
7.2 RESTRAINTS
7.2.1 HIGH COSTS ASSOCIATED WITH IN-VITRO TOXICOLOGY TESTING AND PRODUCTS
7.2.2 COMPLEXITY OF BIOLOGICAL SYSTEMS
7.2.3 NEED FOR SKILLED PERSONNEL AND INFRASTRUCTURE
7.3 OPPORTUNITIES
7.3.1 GROWING ADOPTION OF QUALITY CHECK PRODUCTS TO PREVENT PRODUCT RECALLS
7.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS FOR MARKET EXPANSION
7.3.3 GROWING DEMAND FOR PERSONALIZED MEDICINE AND PRECISION TOXICOLOGY
7.4 CHALLENGES
7.4.1 ETHICAL AND PUBLIC PERCEPTION
7.4.2 REGULATORY ACCEPTANCE AND ENDORSEMENT OF IN-VITRO TESTING METHODS
8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 CONSUMABLES
8.3 SERVICES
8.3.1 CYTOTOXICITY
8.3.2 GENE TOXICITY
8.3.3 HEPATOTOXICITY
8.3.4 OPHTHALMIC TOXICITY
8.3.5 CARDIOTOXICITY
8.3.6 NEPHROTOXICITY
8.3.7 NEUROTOXICITY
8.3.8 OTHERS
8.4 ASSAYS
8.4.1 CELL-BASED ELISA & WESTERN BLOTS
8.4.2 ENZYME TOXICITY ASSAYS
8.4.3 RECEPTOR-BINDING ASSAYS
8.4.4 BACTERIAL TOXICITY ASSAYS
8.4.5 TISSUE CULTURE ASSAYS
8.4.6 OTHER ASSAYS
8.5 EQUIPMENTS
8.6 SOFTWARE
9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST
9.1 OVERVIEW
9.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING
9.3 CYTOTOXICITY TESTING
9.4 GENOTOXICITY TESTING
9.5 DERMAL TOXICITY TESTING
9.6 OCULAR TOXICITY TESTING
9.7 ORGAN TOXICITY TESTING
9.8 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING
9.9 PHOTOTOXICITY TESTING
9.1 OTHER TOXICITY ENDPOINTS AND TESTS
10 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY
10.1 OVERVIEW
10.2 CELL CULTURE TECHNOLOGIES
10.3 HIGH-THROUGHPUT TECHNOLOGIES
10.4 MOLECULAR IMAGING
10.5 OMICS TECHNOLOGY
11 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD
11.1 OVERVIEW
11.2 CELLULAR ASSAYS
11.3 BIOCHEMICAL ASSAYS
11.4 EX-VIVO MODELS
11.5 IN SILICO MODELS
12 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY
12.1 OVERVIEW
12.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
12.2.1 CONSUMABLES
12.2.2 SERVICES
12.2.3 ASSAYS
12.2.4 EQUIPMENTS
12.2.5 SOFTWARE
12.3 DIAGNOSTICS
12.3.1 CONSUMABLES
12.3.2 SERVICES
12.3.3 ASSAYS
12.3.4 EQUIPMENTS
12.3.5 SOFTWARE
12.4 FOOD
12.4.1 CONSUMABLES
12.4.2 SERVICE
12.4.3 ASSAYS
12.4.4 EQUIPMENTS
12.4.5 SOFTWARE
12.5 CHEMICALS
12.5.1 CONSUMABLES
12.5.2 SERVICES
12.5.3 ASSAYS
12.5.4 EQUIPMENTS
12.5.5 SOFTWARE
12.6 COSMETICS AND HOUSEHOLD PRODUCTS
12.6.1 CONSUMABLES
12.6.2 SERVICES
12.6.3 ASSAYS
12.6.4 EQUIPMENTS
12.6.5 SOFTWARE
13 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION
14.1 OVERVIEW
14.2 NORTH AMERICA
14.2.1 U.S.
14.2.2 CANADA
14.2.3 MEXICO
14.3 EUROPE
14.3.1 GERMANY
14.3.2 U.K.
14.3.3 FRANCE
14.3.4 ITALY
14.3.5 RUSSIA
14.3.6 SPAIN
14.3.7 NETHERLANDS
14.3.8 2.8 SWITZERLAND
14.3.9 BELGIUM
14.3.10 TURKEY
14.3.11 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 CHINA
14.4.2 JAPAN
14.4.3 INDIA
14.4.4 AUSTRALIA
14.4.5 SOUTH KOREA
14.4.6 INDONESIA
14.4.7 PHILIPPINES
14.4.8 THAILAND
14.4.9 MALAYSIA
14.4.10 SINGAPORE
14.4.11 REST OF ASIA-PACIFIC
14.5 SOUTH AMERICA
14.5.1 BRAZIL
14.5.2 ARGENTINA
14.5.3 REST OF SOUTH AMERICA
14.6 MIDDLE EAST AND AFRICA
14.6.1 SAUDI ARABIA
14.6.2 SOUTH AFRICA
14.6.3 U.A.E.
14.6.4 EGYPT
14.6.5 ISRAEL
14.6.6 REST OF MIDDLE EAST AND AFRICA
15 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: GLOBAL
15.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
15.3 COMPANY SHARE ANALYSIS: EUROPE
15.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 THERMO FISHER SCIENTIFIC INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 LABCORP DRUG DEVELOPMENT
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 MERCK KGAA
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 CHARLES RIVER LABORATORIES.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 LONZA
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AAT BIOQUEST, INC.
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENTS
17.7 ARAGEN LIFE SCIENCES LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BIOIVT
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO-RAD LABORATORIES, INC.
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 CATALENT, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENT
17.11 CREATIVE BIOARRAY.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENTS
17.12 CREATIVE BIOLABS.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENTS
17.13 CYPROTEX LIMITED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 EUROFINS SCIENTIFIC
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENT
17.15 GENTRONIX
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 IONTOX
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 INSPHERO.
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 INTERTEK GROUP PLC
17.18.1 COMPANY SNAPSHOT
17.18.2 REVENUE ANALYSIS
17.18.3 PRODUCT PORTFOLIO
17.18.4 RECENT DEVELOPMENT
17.19 MB RESEARCH LABORATORIES
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 PREFERRED CELL SYSTEMS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PROMEGA CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 QIAGEN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENTS
17.23 SGS SOCIÉTÉ GÉNÉRALE DE SURVEILLANCE SA
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 SHANGHAI MEDICILON INC.
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
List of Table
TABLE 1 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 2 GLOBAL CONSUMABLES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 GLOBAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL EQUIPMENT IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL SOFTWARE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 GLOBAL CYTOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL GENOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 GLOBAL DERMAL TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL OCULAR TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL ORGAN TOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL PHOTOTOXICITY TESTING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL OTHER TOXICITY ENDPOINTS AND TESTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL CELL CULTURE TECHNOLOGIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 GLOBAL HIGH-THROUGHPUT TECHNOLOGIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL MOLECULAR IMAGING IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 GLOBAL OMICS TECHNOLOGY IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 25 GLOBAL CELLULAR ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 GLOBAL BIOCHEMICAL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 GLOBAL EX-VIVO MODELS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 GLOBAL IN SILICO MODELS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 30 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 32 GLOBAL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 GLOBAL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 34 GLOBAL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 GLOBAL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 36 GLOBAL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 GLOBAL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 38 GLOBAL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 GLOBAL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 40 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 GLOBAL DIRECT TENDER IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 GLOBAL RETAIL SALES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 GLOBAL OTHERS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 59 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 60 U.S. SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 61 U.S. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 62 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 63 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 64 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 65 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 66 U.S. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 67 U.S. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 68 U.S. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 69 U.S. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 70 U.S. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 71 U.S. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 73 CANADA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 74 CANADA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 75 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 76 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 77 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 78 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 79 CANADA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 80 CANADA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 81 CANADA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 82 CANADA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 83 CANADA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 84 CANADA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 85 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 86 MEXICO SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 87 MEXICO ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 88 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 89 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 90 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 91 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 92 MEXICO PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 93 MEXICO DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 94 MEXICO FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 95 MEXICO CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 96 MEXICO COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 97 MEXICO IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 99 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 100 EUROPE SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 101 EUROPE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 102 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 103 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 104 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 105 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 106 EUROPE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 107 EUROPE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 108 EUROPE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 109 EUROPE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 110 EUROPE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 111 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 113 GERMANY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 114 GERMANY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 115 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 116 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 117 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 118 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 119 GERMANY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 120 GERMANY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 121 GERMANY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 122 GERMANY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 123 GERMANY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 124 GERMANY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 125 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 126 U.K. SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 127 U.K. ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 128 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 129 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 130 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 131 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 132 U.K. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 133 U.K. DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 134 U.K. FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 135 U.K. CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 136 U.K. COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 137 U.K. IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 138 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 139 FRANCE SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 140 FRANCE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 141 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 142 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 143 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 144 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 145 FRANCE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 146 FRANCE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 147 FRANCE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 148 FRANCE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 149 FRANCE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 150 FRANCE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 151 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 152 ITALY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 153 ITALY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 154 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 155 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 156 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 157 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 158 ITALY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 159 ITALY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 160 ITALY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 161 ITALY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 162 ITALY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 163 ITALY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 164 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 165 RUSSIA SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 166 RUSSIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 167 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 168 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 169 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 170 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 171 RUSSIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 172 RUSSIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 173 RUSSIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 174 RUSSIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 175 RUSSIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 176 RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 178 SPAIN SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 179 SPAIN ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 180 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 181 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 182 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 183 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 184 SPAIN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 185 SPAIN DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 186 SPAIN FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 187 SPAIN CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 188 SPAIN COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 189 SPAIN IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 190 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 191 NETHERLANDS SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 192 NETHERLANDS ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 193 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 194 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 195 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 196 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 197 NETHERLANDS PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 198 NETHERLANDS DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 199 NETHERLANDS FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 200 NETHERLANDS CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 201 NETHERLANDS COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 202 NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 203 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 204 SWITZERLAND SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 205 SWITZERLAND ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 206 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 207 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 208 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 209 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 210 SWITZERLAND PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 211 SWITZERLAND DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 212 SWITZERLAND FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 213 SWITZERLAND CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 214 SWITZERLAND COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 215 SWITZERLAND IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 216 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 217 BELGIUM SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 218 BELGIUM ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 219 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 220 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 221 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 222 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 223 BELGIUM PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 224 BELGIUM DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 225 BELGIUM FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 226 BELGIUM CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 227 BELGIUM COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 228 BELGIUM IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 229 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 230 TURKEY SERVICE IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 231 TURKEY ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 232 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 233 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 234 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 235 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 236 TURKEY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 237 TURKEY DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 238 TURKEY FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 239 TURKEY CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 240 TURKEY COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 241 TURKEY IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 242 REST OF EUROPE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 243 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 244 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 245 ASIA-PACIFIC SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 246 ASIA-PACIFIC ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 247 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 248 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 249 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 250 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 251 ASIA-PACIFIC PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 252 ASIA-PACIFIC DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 253 ASIA-PACIFIC FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 254 ASIA-PACIFIC CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 255 ASIA-PACIFIC COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 256 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 257 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 258 CHINA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 259 CHINA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 260 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 261 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 262 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 263 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 264 CHINA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 265 CHINA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 266 CHINA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 267 CHINA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 268 CHINA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 269 CHINA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 270 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 271 JAPAN SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 272 JAPAN ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 273 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 274 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 275 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 276 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 277 JAPAN PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 278 JAPAN DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 279 JAPAN FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 280 JAPAN CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 281 JAPAN COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 282 JAPAN IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 283 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 284 INDIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 285 INDIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 286 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 287 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 288 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 289 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 290 INDIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 291 INDIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 292 INDIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 293 INDIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 294 INDIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 295 INDIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 296 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 297 AUSTRALIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 298 AUSTRALIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 299 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 300 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 301 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 302 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 303 AUSTRALIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 304 AUSTRALIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 305 AUSTRALIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 306 AUSTRALIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 307 AUSTRALIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 308 AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 310 SOUTH KOREA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 311 SOUTH KOREA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 312 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 313 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 314 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 315 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 316 SOUTH KOREA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 317 SOUTH KOREA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 318 SOUTH KOREA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 319 SOUTH KOREA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 320 SOUTH KOREA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 321 SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 322 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 323 INDONESIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 324 INDONESIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 325 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 326 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 327 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 328 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 329 INDONESIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 330 INDONESIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 331 INDONESIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 332 INDONESIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 333 INDONESIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 334 INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 335 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 336 PHILIPPINES SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 337 PHILIPPINES ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 338 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 339 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 340 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 341 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 342 PHILIPPINES PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 343 PHILIPPINES DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 344 PHILIPPINES FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 345 PHILIPPINES CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 346 PHILIPPINES COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 347 PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 348 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 349 THAILAND SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 350 THAILAND ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 351 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 352 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 353 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 354 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 355 THAILAND PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 356 THAILAND DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 357 THAILAND FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 358 THAILAND CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 359 THAILAND COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 360 THAILAND IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 361 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 362 MALAYSIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 363 MALAYSIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 364 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 365 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 366 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 367 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 368 MALAYSIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 369 MALAYSIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 370 MALAYSIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 371 MALAYSIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 372 MALAYSIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 373 MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 374 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 375 SINGAPORE SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 376 SINGAPORE ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 377 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 378 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 379 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 380 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 381 SINGAPORE PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 382 SINGAPORE DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 383 SINGAPORE FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 384 SINGAPORE CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 385 SINGAPORE COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 386 SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 387 REST OF ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 388 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 389 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 390 SOUTH AMERICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 391 SOUTH AMERICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 392 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 393 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 394 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 395 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 396 SOUTH AMERICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 397 SOUTH AMERICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 398 SOUTH AMERICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 399 SOUTH AMERICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 400 SOUTH AMERICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 401 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 402 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 403 BRAZIL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 404 BRAZIL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 405 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 406 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 407 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 408 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 409 BRAZIL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 410 BRAZIL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 411 BRAZIL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 412 BRAZIL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 413 BRAZIL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 414 BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 415 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 416 ARGENTINA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 417 ARGENTINA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 418 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 419 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 420 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 421 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 422 ARGENTINA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 423 ARGENTINA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 424 ARGENTINA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 425 ARGENTINA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 426 ARGENTINA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 427 ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 428 REST OF SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 429 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 430 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 431 MIDDLE EAST AND AFRICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 432 MIDDLE EAST AND AFRICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 433 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 434 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 435 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 436 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 437 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 438 MIDDLE EAST AND AFRICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 439 MIDDLE EAST AND AFRICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 440 MIDDLE EAST AND AFRICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 441 MIDDLE EAST AND AFRICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 442 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 443 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 444 SAUDI ARABIA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 445 SAUDI ARABIA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 446 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 447 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 448 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 449 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 450 SAUDI ARABIA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 451 SAUDI ARABIA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 452 SAUDI ARABIA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 453 SAUDI ARABIA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 454 SAUDI ARABIA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 455 SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 456 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 457 SOUTH AFRICA SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 458 SOUTH AFRICA ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 459 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 460 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 461 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 462 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 463 SOUTH AFRICA PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 464 SOUTH AFRICA DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 465 SOUTH AFRICA FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 466 SOUTH AFRICA CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 467 SOUTH AFRICA COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 468 SOUTH AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 469 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 470 U.A.E SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 471 U.A.E ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 472 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 473 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 474 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 475 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 476 U.A.E PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 477 U.A.E DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 478 U.A.E FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 479 U.A.E CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 480 U.A.E COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 481 U.A.E IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 482 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 483 EGYPT SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 484 EGYPT ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 485 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 486 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 487 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 488 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 489 EGYPT PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 490 EGYPT DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 491 EGYPT FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 492 EGYPT CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 493 EGYPT COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 494 EGYPT IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 495 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 496 ISRAEL SERVICES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 497 ISRAEL ASSAYS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 498 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY TOXICOLOGY ENDPOINT AND TEST, 2021-2030 (USD MILLION)
TABLE 499 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 500 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2021-2030 (USD MILLION)
TABLE 501 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2021-2030 (USD MILLION)
TABLE 502 ISRAEL PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 503 ISRAEL DIAGNOSTICS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 504 ISRAEL FOOD IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 505 ISRAEL CHEMICALS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 506 ISRAEL COSMETICS & HOUSEHOLD PRODUCTS IN IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
TABLE 507 ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 508 REST OF MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT AND SERVICE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 2 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR TOXICOLOGY TESTING PRODUCTS AND RAPIDLY GROWING PHARMACEUTICAL AND MEDICAL INDUSTRIES ARE EXPECTED TO DRIVE THE GROWTH OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET FROM 2023 TO 2030
FIGURE 12 THE CONSUMABLES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET IN 2023 & 2030
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SERVICE PROVIDERS IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET
FIGURE 16 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2022
FIGURE 17 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, 2023-2030 (USD MILLION)
FIGURE 18 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, CAGR (2023-2030)
FIGURE 19 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 20 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2022
FIGURE 21 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, 2020-2029 (USD MILLION)
FIGURE 22 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, CAGR (2023-2030)
FIGURE 23 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TOXICOLOGY ENDPOINT AND TEST, LIFELINE CURVE
FIGURE 24 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2022
FIGURE 25 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 26 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, CAGR (2023-2030)
FIGURE 27 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2022
FIGURE 29 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, 2023-2030 (USD MILLION)
FIGURE 30 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, CAGR (2023-2030)
FIGURE 31 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY METHOD, LIFELINE CURVE
FIGURE 32 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2022
FIGURE 33 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, 2023-2030 (USD MILLION)
FIGURE 34 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, CAGR (2023-2030)
FIGURE 35 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY INDUSTRY, LIFELINE CURVE
FIGURE 36 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 37 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 38 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 39 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 41 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2022)
FIGURE 42 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2023 & 2030)
FIGURE 43 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY REGION (2022 & 2030)
FIGURE 44 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 45 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 46 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 47 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 48 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 49 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 50 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 51 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 52 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 53 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 54 EUROPE IN VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 55 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 56 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 57 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 58 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 59 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 60 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 61 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 62 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 63 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 64 SOUTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 65 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: SNAPSHOT (2022)
FIGURE 66 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022)
FIGURE 67 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2023 & 2030)
FIGURE 68 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY COUNTRY (2022 & 2030)
FIGURE 69 MIDDLE EAST AND AFRICA IN-VITRO TOXICOLOGY TESTING MARKET: BY PRODUCT AND SERVICE (2023-2030)
FIGURE 70 GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 71 NORTH AMERICA IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 72 EUROPE IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
FIGURE 73 ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET: COMPANY SHARE 2022 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.